Skip to main content

Table 1 Comparisons of baseline LC and LWR values and clinicopathological features in cohort 1 (N = 378)

From: Lymphocyte count or percentage: which can better predict the prognosis of advanced cancer patients following palliative care?

Clinicopathological features n LC
M (P 25 ~ P 75)
P LWR
M (P 25 ~ P 75)
P
Age (M (P 25 ~ P 75)) 64(56 ~ 73) --   --  
Gender    0.751   0.019
 Male 209(55.29%) 0.8(1.1 ~ 1.5)   0.081(0.133 ~ 0.194)  
 Female 169(44.71%) 0.8(1.1 ~ 1.5)   0.095(0.145 ~ 0.222)  
Tumor stage    0.586   0.058
 III 23(6.08%) 0.9(1.2 ~ 1.5)   0.127(0.190 ~ 0.214)  
 IV 355(93.92%) 0.8(1.1 ~ 1.5)   0.084(0.136 ~ 0.207)  
Primary tumor site    0.110   0.308
 Gastrointestinal tumors 198(52.38%) 0.7(1 ~ 1.4)   0.081(0.131 ~ 0.190)  
 Thoracic cancer 86(22.75%) 0.9(1.2 ~ 1.7)   0.092(0.142 ~ 0.213)  
 Urogenital neoplasms 59(15.61%) 0.8(1.1 ~ 1.6)   0.088(0.147 ~ 0.235)  
 Head and neck neoplasm 16(4.23%) 0.8(1.1 ~ 1.4)   0.089(0.137 ~ 0.246)  
 Other tumors 19(5.03%) 0.9(1.3 ~ 1.6)   0.099(0.171 ~ 0.245)  
Family history    0.935   0.999
 No 264(70.78%) 0.8(1.1 ~ 1.5)   0.083(0.141 ~ 0.203)  
 Yes 109(29.22%) 0.8(1.1 ~ 1.5)   0.091(0.127 ~ 0.222)  
 Unknown 5     
Smoking history    0.478   0.005
 No 265(71.62%) 0.8(1.1 ~ 1.5)   0.092(0.145 ~ 0.214)  
 Yes 105(28.38%) 0.8(1 ~ 1.5)   0.075(0.118 ~ 0.185)  
 Unknown 8     
ECOG    0.564   <0.001
  < 3 218(57.67%) 0.8(1.1 ~ 1.5)   0.094(0.146 ~ 0.231)  
  > =3 160(42.33%) 0.8(1.1 ~ 1.5)   0.072(0.113 ~ 0.173)  
Concomitant disease    0.440   0.968
 No 229(60.58%) 0.8(1.1 ~ 1.5)   0.085(0.138 ~ 0.214)  
 Yes 149(39.42%) 0.8(1.1 ~ 1.6)   0.088(0.139 ~ 0.198)  
Nutrient status    0.012   <0.001
 Normal 107(28.50%) 0.8(1.2 ~ 1.6)   0.108(0.169 ~ 0.233)  
 Abnormal 268(71.50%) 0.8(1 ~ 1.45)   0.079(0.129 ~ 0.196)  
 Unknown 3     
  1. LC lymphocyte count; LWR lymphocyte to white blood cell ratio